The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1

Yanlai Lai, Meihua Song, Kevin Hakala, Susan E Weintraub, Yuzuru Shiio

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Inactivation of the von Hippel-Lindau (VHL) tumor suppressor is associated with renal carcinoma, hemangioblastoma and pheochromocytoma. The VHL protein is a component of a ubiquitin ligase complex that ubiquitinates and degrades hypoxia inducible factor-α (HIF-α). Degradation of HIF-α by VHL is proposed to suppress tumorigenesis and tumor angiogenesis. Several lines of evidence also suggest important roles for HIF-independent VHL functions in tumor suppression and other biological processes. Using GST-VHL pull-down experiment and mass spectrometry, we detected an interaction between VHL and heterochromatin protein 1 (HP1). We identified a conserved HP1-binding motif (PXVXL) in the β domain of VHL, which is disrupted in a renal carcinoma-associated P81S mutant. We show that the VHL P81S mutant displays reduced binding to HP1, yet retains the ability to interact with elongin B, elongin C, and cullin 2 and is fully capable of degrading HIF-a. We also demonstrate that HP1 increases the chromatin association of VHL. These results suggest a role for the VHL-HP1 interaction in VHL chromatin targeting.

Original languageEnglish (US)
Pages (from-to)103-110
Number of pages8
JournalArchives of Biochemistry and Biophysics
Volume518
Issue number2
DOIs
StatePublished - Feb 15 2012

Fingerprint

Von Hippel-Lindau Tumor Suppressor Protein
Tumors
Chromatin
Cullin Proteins
Hemangioblastoma
Carcinoma
Kidney
Biological Phenomena
Neoplasms
Pheochromocytoma
Ligases
Ubiquitin
Protein Binding
Mass spectrometry
Mass Spectrometry
Carcinogenesis
Display devices
heterochromatin-specific nonhistone chromosomal protein HP-1
Association reactions
Degradation

Keywords

  • Heterochromatin protein 1
  • Interaction
  • Mass spectrometry
  • Renal carcinoma
  • Von Hippel-Lindau tumor suppressor

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1. / Lai, Yanlai; Song, Meihua; Hakala, Kevin; Weintraub, Susan E; Shiio, Yuzuru.

In: Archives of Biochemistry and Biophysics, Vol. 518, No. 2, 15.02.2012, p. 103-110.

Research output: Contribution to journalArticle

@article{ebdad5209fe2409c927953e1dcdc618d,
title = "The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1",
abstract = "Inactivation of the von Hippel-Lindau (VHL) tumor suppressor is associated with renal carcinoma, hemangioblastoma and pheochromocytoma. The VHL protein is a component of a ubiquitin ligase complex that ubiquitinates and degrades hypoxia inducible factor-α (HIF-α). Degradation of HIF-α by VHL is proposed to suppress tumorigenesis and tumor angiogenesis. Several lines of evidence also suggest important roles for HIF-independent VHL functions in tumor suppression and other biological processes. Using GST-VHL pull-down experiment and mass spectrometry, we detected an interaction between VHL and heterochromatin protein 1 (HP1). We identified a conserved HP1-binding motif (PXVXL) in the β domain of VHL, which is disrupted in a renal carcinoma-associated P81S mutant. We show that the VHL P81S mutant displays reduced binding to HP1, yet retains the ability to interact with elongin B, elongin C, and cullin 2 and is fully capable of degrading HIF-a. We also demonstrate that HP1 increases the chromatin association of VHL. These results suggest a role for the VHL-HP1 interaction in VHL chromatin targeting.",
keywords = "Heterochromatin protein 1, Interaction, Mass spectrometry, Renal carcinoma, Von Hippel-Lindau tumor suppressor",
author = "Yanlai Lai and Meihua Song and Kevin Hakala and Weintraub, {Susan E} and Yuzuru Shiio",
year = "2012",
month = "2",
day = "15",
doi = "10.1016/j.abb.2011.12.023",
language = "English (US)",
volume = "518",
pages = "103--110",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1

AU - Lai, Yanlai

AU - Song, Meihua

AU - Hakala, Kevin

AU - Weintraub, Susan E

AU - Shiio, Yuzuru

PY - 2012/2/15

Y1 - 2012/2/15

N2 - Inactivation of the von Hippel-Lindau (VHL) tumor suppressor is associated with renal carcinoma, hemangioblastoma and pheochromocytoma. The VHL protein is a component of a ubiquitin ligase complex that ubiquitinates and degrades hypoxia inducible factor-α (HIF-α). Degradation of HIF-α by VHL is proposed to suppress tumorigenesis and tumor angiogenesis. Several lines of evidence also suggest important roles for HIF-independent VHL functions in tumor suppression and other biological processes. Using GST-VHL pull-down experiment and mass spectrometry, we detected an interaction between VHL and heterochromatin protein 1 (HP1). We identified a conserved HP1-binding motif (PXVXL) in the β domain of VHL, which is disrupted in a renal carcinoma-associated P81S mutant. We show that the VHL P81S mutant displays reduced binding to HP1, yet retains the ability to interact with elongin B, elongin C, and cullin 2 and is fully capable of degrading HIF-a. We also demonstrate that HP1 increases the chromatin association of VHL. These results suggest a role for the VHL-HP1 interaction in VHL chromatin targeting.

AB - Inactivation of the von Hippel-Lindau (VHL) tumor suppressor is associated with renal carcinoma, hemangioblastoma and pheochromocytoma. The VHL protein is a component of a ubiquitin ligase complex that ubiquitinates and degrades hypoxia inducible factor-α (HIF-α). Degradation of HIF-α by VHL is proposed to suppress tumorigenesis and tumor angiogenesis. Several lines of evidence also suggest important roles for HIF-independent VHL functions in tumor suppression and other biological processes. Using GST-VHL pull-down experiment and mass spectrometry, we detected an interaction between VHL and heterochromatin protein 1 (HP1). We identified a conserved HP1-binding motif (PXVXL) in the β domain of VHL, which is disrupted in a renal carcinoma-associated P81S mutant. We show that the VHL P81S mutant displays reduced binding to HP1, yet retains the ability to interact with elongin B, elongin C, and cullin 2 and is fully capable of degrading HIF-a. We also demonstrate that HP1 increases the chromatin association of VHL. These results suggest a role for the VHL-HP1 interaction in VHL chromatin targeting.

KW - Heterochromatin protein 1

KW - Interaction

KW - Mass spectrometry

KW - Renal carcinoma

KW - Von Hippel-Lindau tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=84859234216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859234216&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2011.12.023

DO - 10.1016/j.abb.2011.12.023

M3 - Article

VL - 518

SP - 103

EP - 110

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 2

ER -